The Medical Treatment of Inflammatory Breast Cancer

Shaheenah Dawood, Naoto T. Ueno, Massimo Cristofanilli*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

The multidisciplinary management of inflammatory breast cancer (IBC) includes neoadjuvant systemic chemotherapy, surgery, radiotherapy, and, in hormone receptor-positive disease, hormonal therapy. The use of induction chemotherapy with anthracyclines and taxanes somewhat improved the prognosis and local control of patients with IBC compared to local modalities alone. Improved understanding of the biological features of the disease has allowed for the development of targeted therapies (eg, trastuzumab and lapatinib) that are changing the outcome of this aggressive disease.

Original languageEnglish (US)
Pages (from-to)64-71
Number of pages8
JournalSeminars in Oncology
Volume35
Issue number1
DOIs
StatePublished - Feb 1 2008

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'The Medical Treatment of Inflammatory Breast Cancer'. Together they form a unique fingerprint.

Cite this